lipoprotein lipase activity
Recently Published Documents


TOTAL DOCUMENTS

775
(FIVE YEARS 14)

H-INDEX

66
(FIVE YEARS 3)

2021 ◽  
Vol 14 (11) ◽  
pp. e246698
Author(s):  
Lauré M Fijen ◽  
Aldo Grefhorst ◽  
Johannes H M Levels ◽  
Danny M Cohn

Severe hypertriglyceridemia is a major risk factor for acute pancreatitis. In exceptional cases, it is caused by plasma components inhibiting lipoprotein lipase activity. This phenomenon is predominantly associated with autoimmune diseases. Here, we report a case of severe hypertriglyceridemia due to a transient reduction in lipoprotein lipase activity following an episode of COVID-19 in an otherwise healthy 45-year-old woman. The lipoprotein lipase activity of the patient was markedly reduced compared with a healthy control and did recover to 20% of the healthy control’s lipoprotein lipase activity 5 months after the COVID-19 episode. Mixing tests substantiated reduced lipolytic capacity in the presence of the patient’s plasma at presentation compared with a homozygous lipoprotein lipase-deficient control, which was no longer present at follow-up. Western blotting confirmed that the quantity of lipoprotein lipase was not aberrant. Fibrate treatment and a strict hypolipidemic diet improved the patient’s symptoms and triglyceride levels.


Author(s):  
Kelli L. Sylvers-Davie ◽  
Brandon S.J. Davies

Triglyceride-rich lipoproteins deliver fatty acids to tissues for oxidation and for storage. Release of fatty acids from circulating lipoprotein triglycerides is carried out by lipoprotein lipase (LPL), thus LPL serves as a critical gatekeeper of fatty acid uptake into tissues. LPL activity is regulated by a number of extracellular proteins including three members of the angiopoietin-like family of proteins. In this review we discuss our current understanding of how, where, and when ANGPTL3, ANGPTL4, and ANGPTL8 regulate lipoprotein lipase activity, with a particular emphasis on how these proteins interact with each other to coordinate triglyceride metabolism and fat partitioning.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Bimit Mahat ◽  
Étienne Chassé ◽  
Jean-François Mauger ◽  
Pascal Imbeault

An amendment to this paper has been published and can be accessed via the original article.


2020 ◽  
Vol 77 ◽  
pp. 101630
Author(s):  
Takaharu Hirai ◽  
Noriyoshi Usui ◽  
Keiko Iwata ◽  
Taishi Miyachi ◽  
Kenji J. Tsuchiya ◽  
...  

2019 ◽  
Vol 120 (1) ◽  
pp. 117-125 ◽  
Author(s):  
Monika Górecka ◽  
Krzysztof Krzemiński ◽  
Monika Buraczewska ◽  
Agnieszka Kozacz ◽  
Jan Dąbrowski ◽  
...  

Abstract Purpose Angiopoietin-like protein 4 (ANGPTL4) regulates lipid metabolism by inhibiting lipoprotein lipase activity and stimulating lipolysis in adipose tissue. The aim of this study was to find out whether the mountain ultra-marathon running influences plasma ANGPTL4 and whether it is related to plasma lipid changes. Methods Ten healthy men (age 31 ± 1.1 years) completed a 100-km ultra-marathon running. Plasma ANGPTL4, free fatty acids (FFA), triacylglycerols (TG), glycerol (Gly), total cholesterol (TC), low (LDL-C) and high (HDL-C) density lipoprotein-cholesterol were determined before, immediately after the run and after 90 min of recovery. Results Plasma ANGPTL4 increased during exercise from 68.0 ± 16.5 to 101.2 ± 18.1 ng/ml (p < 0.001). This was accompanied by significant increases in plasma FFA, Gly, HDL-C and decreases in plasma TG concentrations (p < 0.01). After 90 min of recovery, plasma ANGPTL4 and TG did not differ significantly from the exercise values, while plasma FFA, Gly, TC and HDL-C were significantly lower than immediately after the run. TC/HDL-C and TG/HDL-C molar ratios were significantly reduced. The exercise-induced changes in plasma ANGPTL4 correlated positively with those of FFA (r = 0.73; p < 0.02), and HDL-C (r = 0.69; p < 0.05). Positive correlation was found also between plasma ANGPTL4 and FFA concentrations after 90 min of recovery (r = 0.77; p < 0.01). Conclusions The present data suggest that increase in plasma FFA during mountain ultra-marathon run may be involved in plasma ANGPTL4 release and that increase in ANGPTL4 secretion may be a compensatory mechanism against fatty acid-induced oxidative stress. Increase in plasma HDL-C observed immediately after the run may be due to the protective effect of ANGPTL4 on HDL.


2019 ◽  
Vol 10 ◽  
Author(s):  
Alwin Kamermans ◽  
Merel Rijnsburger ◽  
Ananya Chakraborty ◽  
Susanne van der Pol ◽  
Helga E. de Vries ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document